Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 2,449 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Implant Clear all

Conditions: Chronic Pain, Intractable Pain
Interventions: Commercially available Inceptiv™ neurostimulation systems; Device
Lead sponsor: Medtronic; Industry
Eligibility: 18 Years and older
Enrollment: 970 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2034
U.S. locations: 10
States / cities: Phoenix, Arizona • Roseville, California • San Diego, California + 7 more

Conditions: Arrhythmias, Cardiac
Interventions: MRI Scan; Device
Lead sponsor: Essentia Health; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Duluth, Minnesota

Conditions: Preimplantation Gentic Screening (PGS), In Vitro Fertilization (IVF), Preimplantation Genetic Diagnosis (PGD)
Interventions: 24 Chromosome Aneuploidy Screening with Parental Support; Device
Lead sponsor: Natera, Inc.; Industry
Eligibility: 35 Years to 42 Years · Female only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 9
States / cities: Laguna Hills, California • Washington D.C., District of Columbia • Clearwater, Florida + 6 more

Conditions: Diabetic Macular Edema
Interventions: triamcinolone acetonide; Drug
Lead sponsor: SurModics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 4
States / cities: Phoenix, Arizona • Santa Barbara, California • Detroit, Michigan + 1 more

Conditions: IUD Insertion
Interventions: Vaginal 2% Lidocaine, Surgical Lubricant Jelly; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pancreatic Cancer
Interventions: Directional Brachytherapy Source Implant; Device
Lead sponsor: CivaTech Oncology; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 6
States / cities: Tampa, Florida • Chicago, Illinois • Oak Lawn, Illinois + 3 more

Conditions: ESI-related Bleeding
Interventions: Doxycycline, Placebo; Drug
Lead sponsor: Petra M. Casey; Other
Eligibility: 18 Years to 51 Years · Female only
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Atrial Fibrillation, Left Atrial Appendage Thrombosis
Interventions: Intracardiac Echocardiography (ICE); Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Ventricular Tachycardia
Interventions: clonidine, metoprolol; Drug
Lead sponsor: James Martins; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Breast Reconstruction After Mastectomy
Interventions: NRI implantation; Device
Lead sponsor: FixNip Ltd; Industry
Eligibility: 22 Years and older · Female only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Primary Open Angle Glaucoma
Interventions: Placement of the sponge, Mitomycin-C; Procedure · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: PVC - Premature Ventricular Contraction, Myocarditis
Interventions: Monitoring of patients presenting with PVCs; Other
Lead sponsor: Kansas City Heart Rhythm Research Foundation; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Timeline: 2022 – 2025
U.S. locations: 6
States / cities: Overland Park, Kansas • Independence, Missouri • Kansas City, Missouri

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Congestive Heart Failure, Medical Device
Interventions: Not listed
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Maxillary Sinus Bone Loss
Interventions: INFUSE® Bone Graft; Device
Lead sponsor: Medtronic Spinal and Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 5
States / cities: Fullerton, California • Denver, North Carolina • Philadelphia, Pennsylvania + 2 more

Conditions: Heart Failure, Ischemic Cardiomyopathy, ICD Patients
Interventions: 18F-metaFluorobenzylguanidine, Rubidium-82; Drug
Lead sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC); Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthy
Interventions: Implant insertion device; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 49 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Sudden Cardiac Death
Interventions: Not listed
Lead sponsor: Pocono Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: East Stroudsburg, Pennsylvania

Conditions: Hearing Loss, Sensorineural, Hearing Loss, Bilateral
Interventions: Cochlear implantation; Device
Lead sponsor: Cochlear; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 8
States / cities: Tucson, Arizona • Los Angeles, California • St Louis, Missouri + 5 more

Conditions: Intubation, Intratracheal, Multidetector Computed Tomography
Interventions: Not listed
Lead sponsor: Javier H Campos; Other
Eligibility: 18 Years to 90 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Congenital Mullerian Duct Anomaly
Interventions: biologic vaginal-construct implantation; Biological
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 15 Years to 45 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Breast Reconstruction, Breast Augmentation, Breast Revision
Interventions: Mentor Round Low Bleed Gel-filled Mammary Protheses, both Siltex and Smooth Surface; Device
Lead sponsor: Mentor Worldwide, LLC; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,008 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2012
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Posterior Spinal Fusion
Interventions: Pediguard; Device
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: Not listed
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 6
States / cities: Golden, Colorado • Miami, Florida • Louisville, Kentucky + 2 more

Conditions: Uveitis
Interventions: 0.59 mg Fluocinolone Acetonide implant; Drug
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy

Study to Monitor Patients With Pacemakers or ICDs Who Undergo MRI Scans

Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer

Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema

Self-Administered Lidocaine Gel for Pain Management With IUD Insertion

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Management of Etonogestrel Subdermal Implant-related Bleeding

Intracardiac Echocardiography Guided Watchman Device Implant

Clonidine to Prevent Implantable Cardiovertor Defibrillator Firing

PREFIX FEASIBILITY Study - PRojection & Safety Evaluation of the FIXNip Nipple Reconstruction Implant

The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device

Role of Novel ILR in the Management of PVCs

Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement

Use of Defibrillator Information in the Emergency Department

Sinus Augmentation With Dental Implant

18F-mFBG Imaging for Myocardial Sympathetic Innervation

Assessing the Safety and Efficacy of a Novel Subcutaneous Implant Insertion Device on Healthy Adults

Study of Paced QRS Duration as a Marker of Sudden Cardiac Death

Hearing Loss in Older Adults Study

Influence of Tracheal-bronchial Anatomy Changes on Multi-detector Computed Tomography Scan of the Chest Upon Placement of Left-Sided Double Lumen Endotracheal Tube

Implantation Of Vaginal Construct For Patients With Vaginal Aplasia

Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses

Evaluation of the PediGuard™ for Pedicle Screw Insertion

Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment